RankAlpha logo
Back to Rankings

TMO

Thermo Fisher ScientificB
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
The Q2 beat, raised outlook, 5% organic growth, margin expansion, broad end-market improvement, and continued capital deployment support a constructive recovery thesis [#SEC-8K-2026-07-23].
Posture
Constructive
Lead driver
Sentiment
What changed
6 setup hits (3d) with net bullish as of 2026-09-09.
What can break
Acquisition synergies and benefits, including from Clario, may fall short; the microbiology divestiture also carries execution and earnings-mix risk [#SEC-8K-2026-07-23].
Momentum
75
Value
62
Sentiment
65
Setup hits (3d)
6 · Net Bullish
AI TargetsBase $630.00 · Bull $680.00 · Bear $500.00Analysis 2026-07-28; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-28 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-10

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bullish
Target $653.56
Why
Momentum75 · Δ7d -10.8
Value62 · Δ7d -0.0
Sentiment65 · Δ7d +3.3
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • 6 setup hits (3d) with net bullish as of 2026-09-09.
  • • Sentiment remains the lead driver in the composite, 7D delta +3.3.

Contradictions & invalidation

  • • Acquisition synergies and benefits, including from Clario, may fall short; the microbiology divestiture also carries execution and earnings-mix risk [#SEC-8K-2026-07-23].
  • • Customer capital spending and government-funded demand may not remain on the improving trajectory.
  • • The positive print is partly reflected in the stock, while durable demand recovery, acquisition benefits, and continuation of customer spending improvement remain execution-dependent.

Catalyst clock

2026-07-23

Q2 beat and higher 2026 outlook

Lead driver: Sentiment · See AI snapshot
Momentum
75
9% active weight
Current posture
7d trendSoftening
Δ7d
-10.8
Δ21d
-3.3
Value
62
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.5
Sentiment
65
62% active weight
Current posture
7d trendImproving
Δ7d
+3.3
Δ21d
+0.6
Why this grade

Composite grade B. Momentum 74.6 / Value 62.3 / Sentiment 64.8

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-07-28. Scenario method

B+
Bull case
25%
Probability
Target price
$680.00
Analysis reference price unavailable
Analysis 2026-07-28 · RankAlpha Sentiment Codex
Most likely
B
Base case
55%
Probability
Target price
$630.00
Analysis reference price unavailable
Analysis 2026-07-28 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$500.00
Analysis reference price unavailable
Analysis 2026-07-28 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$216.49B
Beta
0.93
Shares Out
369.75M
P/E (TTM)
35.3
P/S (TTM)
5.25
P/FCF (TTM)
41.85
Rev YoY
+10.5%
EPS YoY
+9.4%
Gross Margin
+40.2%
Op Margin
+19.1%
Net Debt
$30.75B
Current Ratio
1.55
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data